SCHEMBL9422967

SCHEMBL9422967

CCCCc1nc(=O)n2nc(-c3ccccc3)cc2[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 7/20 0.47
GSK3B P49841 2/20 0.46
PDE10A Q9Y233 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
ADORA1 P30542 2/20 0.41
ADORA3 P0DMS8 1/20 0.41
ADORA2A P29274 1/20 0.41
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 2/20 0.39
HSD17B10 Q99714 2/20 0.39
NPC1 O15118 1/20 0.39
TP53 P04637 1/20 0.39
HPGD P15428 1/20 0.39
RAB9A P51151 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
PDE6D O43924 1/20 0.37
PDE5A O76074 1/20 0.37
PDE6A P16499 1/20 0.37
PDE6G P18545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9423003 0.88 GSK3B (0.44) PARP1GSK3BADORA1ADORA3ADORA2A
SCHEMBL9423324 0.81 PARP1 (0.50) PARP1GSK3BSMN1; SMN2ADORA1ADORA3
SCHEMBL10631883 0.74 PARP1 (0.51) PARP1SMN1; SMN2ALDH1A1KDM4ENPC1
SCHEMBL9422938 0.72 GSK3B (0.44) PARP1GSK3BALDH1A1KDM4E
SCHEMBL10634525 0.71 KMT2A (0.53) PARP1SMN1; SMN2ALDH1A1NPC1HPGD
SCHEMBL13534960 0.69 PARP1 (0.51) PARP1ADORA2AALDH1A1KDM4EHSD17B10
SCHEMBL15191719 0.69 PARP1 (0.57) PARP1SMN1; SMN2ADORA3ALDH1A1KDM4E
SCHEMBL9423168 0.68 PARP1 (0.42) PARP1GSK3BALDH1A1
SCHEMBL10634702 0.68 ABCB1 (0.60) PDE10ASMN1; SMN2ALDH1A1KDM4EHSD17B10
SCHEMBL10634509 0.68 HTT (0.47) PARP1GSK3BSMN1; SMN2ALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5358947-A Treating hypertension, congestive heart failure AMERICAN CYANAMID COMPANY (US) 1994-10-25 US disclosed